Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol versus atenolol effects on central aortic pressure in hypertensive patients
2007-003549-33Phase 4Completed
- Sponsor
- Menarini Group
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in essential hypertension comparing Nebivolol with Atenolol (2 arms). Primary endpoints: Change in augmentation index after 10 weeks and Sample size justification for augmentation index difference. Started Sep 2007; status: completed.
02
Drugs
nebivololatenolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2007-003549-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003549-33.